Compound ID | 1211

CS-4771

Details of activity: TLR4 inhibitor
Institute where first reported: Daiichi Sankyo
Year first mentioned: 2014
Highest developmental phase: Phase 1
Development status: Inactive

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.